Notable examples of this include the SCN1A-associated seizure disorders where commonly used sodium-channel-blocking medications carbamazepine, vigabatrin and lamotrigine should be avoided because they may worsen the condition by inducing and/or prolonging seizures [5]. This evidence concerns the gene SCN1A and epilepsy.